Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...

Sure, here is the description with all links and additional text removed: If you found this video enjoyable, kindly show your ...

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder in which molecular pathology, cellular stress and network dysfunction accumulate over many years before dementia becomes clinically ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s ...

Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.